DUBLIN--(BUSINESS WIRE)--The "Cell and Gene Therapy World Market and Market Potential" report has been added to ResearchAndMarkets.com's offering.
The report examines developments in cell and gene therapy markets by condition/disorder, including principal products, trends in research and development, market breakdown of cell and gene therapies, regional market summary, and competitor summary.
Companies Mentioned
- Advaxis, Inc. (Biosight Therapeutics)
- Allosource
- Alnylam Pharmaceuticals, Inc.
- Amgen
- Anges Inc.
- Anterogen Co Ltd.
- Atara Biotherapeutics
- Athersys, Inc
- Biocardia
- Biogen, Inc.
- Biomarin Pharmaceuticals
- Bluebird Bio, Inc.
- Brainstorm Cell Therapeutics
- Bristol-Myers Squibb
- Caladrius Biosciences
- Candel Therapeutics
- Castle Creek Biosciences
- Celyad Oncology
- Cook Myosite, Inc
- Cytori Therapeutics, Inc
- Dendreon Pharmaceuticals LLC
- Fergene, Inc/Ferring Pharmaceuticals
- Gamida Cell Ltd.
- Gensight Biologics S.A.
- Gilead Sciences, Inc.
- And Many More Companies!
The following conditions/disorders are covered:
Dermatology, including:
- Dermatology Cell and Gene Therapy Markets by Product Type, Estimated 2021 and Projected 2026 and 2031 ($ millions) (Stem cells, Skin cells)
- Dermatology Cell and Gene Therapy Market by General Indication, Estimated 2021, Projected 2026 and 2031 ($ millions) (Wound healing/treatment, Other indications [wrinkles, scar treatment])
- Dermatology Cell and Gene Therapy Market by Country/Region, Estimated 2021, Projected 2026 and 2031 ($ millions) (United States, Europe/European Union, S. Korea, Other countries)
- Dermatology Cell and Gene Therapy Competitor Market Share, Reported and Estimated 2021 ($ millions)
Cardiovascular and Blood Disorders, including:
- Cardiovascular and Blood Disorders Cell and Gene Therapy Markets by Product Type, Estimated 2021 and Projected 2026 and 2031 ($ millions) (Stem cells, Gene therapy, Other cell therapies; Stromal cells)
- Cardiovascular and Blood Disorders Cell and Gene Therapy Market by General Indication, Estimated 2021, Projected 2026 and 2031 ($ millions) (Cardiac disorders, Vascular disorders, Blood disorders, Hypercholesterolemia)
- Cardiovascular and Blood Disorders Cell and Gene Therapy Market Summary by Geographic Region, Estimated 2021 and Projected 2026, 2030 ($ millions) (United States, Europe, S. Korea, Japan, ROW)
Oncology, including:
- Oncology Cell and Gene Therapy Markets by Product Type, Estimated 2021 and Projected 2026 and 2031 ($ millions) (CAR-T, Cell immunotherapy, Gene therapy, Other cell therapy)
- Oncology Cell and Gene Therapy Market by General Indication, Estimated 2021, Projected 2026 and 2031 ($ millions) (Blood cancers, Prostate cancer, Melanoma, Other cancers)
- Oncology Cell and Gene Therapy Market Summary by Geographic Region, Estimated 2021 and Projected 2026, 2030 ($ millions) (United States, Europe, ROW)
- Oncology Cell and Gene Therapy Competitor Market Share, Reported and Estimated 2021 ($ millions)
Ophthalmic Conditions, including:
- Ophthalmology Cell and Gene Therapy Markets by Product Type, Estimated 2021 and Projected 2026 and 2031 ($ millions) (Stem cells, Gene therapy, Other cell therapy)
- Ophthalmology Cell and Gene Therapy Market Summary by Geographic Region, Estimated 2021 and Projected 2026, 2030 ($ millions) (United States, Europe, Other countries)
Musculoskeletal Conditions and Disorders, including:
- Musculoskeletal Cell Therapy Market, Estimated 2021 and Projected 2026 and 2031 ($ millions)
- Musculoskeletal Cell and Gene Therapy Market by General Indication, Estimated 2021, Projected 2026 and 2031 ($ millions) (Cartilage Defect/Damage Repair, Bone Defect/Damage Repair, Others [tendon damage, osteoarthritis])
- Musculoskeletal Cell and Gene Therapy Market by Country/Region, Estimated 2021, Projected 2026 and 2031 ($ millions) (United States, Europe/European Union, S. Korea, Other countries)
- Musculoskeletal Cell Therapy Competitor Market Share, Reported and Estimated 2021 ($ millions)
Other Conditions, including:
- Other Conditions Cell and Gene Therapy Markets by Product Type, Estimated 2021 and Projected 2026 and 2031 ($ millions) (Cell therapy, Gene therapy, Gene-modified cell therapy)
- Other Conditions Cell and Gene Therapy Market by Country/Region, Estimated 2021, Projected 2026 and 2031 ($ millions) (United States, Europe/European Union, S. Korea, Other countries)
Key Topics Covered:
CHAPTER 1: EXECUTIVE SUMMARY
CHAPTER 2: INTRODUCTION TO CELL AND GENE THERAPY
CHAPTER 3: CELL AND GENE THERAPY MARKETS IN DERMATOLOGY OVERVIEW
CHAPTER 4: CELL AND GENE THERAPY MARKETS IN CARDIOVASCULAR AND BLOOD DISORDERS
CHAPTER 5: CELL AND GENE THERAPY MARKETS IN ONCOLOGY
CHAPTER 6: CELL AND GENE THERAPY MARKETS IN OPHTHALMIC CONDITIONS
CHAPTER 7: CELL AND GENE THERAPY MARKETS IN MUSCULOSKELETAL CONDITIONS AND DISORDERS
CHAPTER 9: CELL AND GENE THERAPY MARKETS IN OTHER CONDITIONS
CHAPTER 10: CELL AND GENE THERAPY MARKET REVIEW
CHAPTER 11: MARKET PARTICIPANTS
For more information about this report visit https://www.researchandmarkets.com/r/9zzs53
